Optibiotix Health (OPTI)

 

OPTI Share PerformanceMore

52 week high90.00 03/04/17
52 week low59.00 10/05/17
52 week change -8.00 (-9.82%)
4 week volume6,341,060 27/04/17

Media for (OPTI)

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

OptiBiotix Health launches LPLDL,SlimBiome products

OptiBiotix Health has announced the successful launch of its SlimBiome and LPLDL products. "We are extremely pleased ...

Successful launch of LPLDL and SlimBiome products

RNS Number: 1779F OptiBiotix Health PLC 16 May 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") Successful Launch of LP LDL and SlimBiome products at Vitafoods 2017 OptiB i ot i x H ealth p l c (A I M :O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, and d ia b ete s a nn o un ces the su...

OptiBiotix notes non-exclusive European licence deal

OptiBiotix Health has agreed to grant a non-exclusive license agreement to Nutrilinea for the production and commercialis...

LPLDL? Non-Exclusive European License Agreement

RNS Number: 5111E OptiBiotix Health PLC 09 May 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") LP LDL Non-Exclusive European License Agreement OptiB i ot i x H ealth p l c (A I M: O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, a nn o un ces that it has agree...

Presentation of abstract at conference

RNS Number: 9415D OptiBiotix Health PLC 03 May 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") Presentation of abstract at Probiotics and Prebiotics conference OptiB i ot i x H ealth p l c (A I M :O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, announces that it ha...

Optibiotix discusses 'critical' couple of years

The next 24-36 months will be crucial for this life sciences minnow, as it nears product commercialisation, its boss tells Dav...

Optibiotix Health notes first German sales of LPLDL

OptiBiotix Health has agreed to supply 100,000 units of LPLDL to HLH BioPharma Vertriebs GmbH (HLH). HLH had mo...

First German sales

RNS Number: 2319D OptiBiotix Health PLC 25 April 2017 OptiBiotix Health plc ("OptiBiotix" or the "Company") First sales of LP LDL to German market OptiB i ot i x H ealth p l c (A I M :O P TI), a li f e sc i ences bu s i n ess d e ve l o p i n g c o m p o u n d s to tack l e o b esi t y, h i g h chole s te r ol, d ia b ete s and skin care, a nn o un ces that it has agreed to supply...

Fundamental DataMore

EPS-1.67
Dividend yield0 %

Equity Research (OPTI)

OptiBiotix Health plc
30/08/2016
The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes has reported another half (to May 2016) of strong scientific and commercial progress. Operational...
OptiBiotix Health plc
28/07/2016
The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes has announced the successful completion of a trial launch for its Slimbiome® ingredients in a range of...
OptiBiotix Health plc
19/07/2016
New patent filing suggests multiple routes to market for cholesterol strain The Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes has announced the filing...

Latest discussion posts More

  • SBTX

    Dr Cath O'Neill interview this ...
    22-May-2017
    mol42
  • Recent Article

    http://www.naturalpharmacybusiness.com/imag/npbmay2017/ pages 8-9 mol
    18-May-2017
    mol42
  • Re: RNS - Draft Contracts

    Patience reqd.
    18-May-2017
    green.as1953

Users' HoldingsMore

Users who hold Optibiotix Health also hold..
LLOYDS GRP.20%
SIRIUS MINERALS10%
NATIONAL GRID10%
BT GROUP9%
GLAXOSMITHKLINE9%

Codes & Symbols

ISINGB00BP0RTP38
SymbolsOPTI, LSE:OPTI, OPTI.L, OPTI:LN, LON:OPTI, XLON:OPTI